I don't think they are obligated to, you know the activities report will be a September duplicate though the cash flow would be handy.. Hefty admin costs but I guess the 2 new directors and 2 previous as advisors would quickly add up..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025